Moleculin Biotech (MBRX) Financials

$0.71

$0.03 (5.09%)

As on 04-Sep-2026 16:27EDT

Market cap

$14 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

0

P/B Ratio

1.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.04	0.09	0.13	0.13	0.22	0.26
Gross Profit	-0.04	-0.09	-0.13	-0.13	-0.22	-0.26
Operating Expenses	28.87	25.10	26.64	29.63	30.64	22.97
Operating Profit (EBIT)	-28.87	-25.10	-26.64	-29.63	-30.64	-22.97
Other Income	--	--	--	--	--	--
Profit before Tax	-30.33	-33.56	-21.76	-29.77	-29.03	-15.89
Provision for Tax	--	--	--	--	-1.62	-7.03
Profit after Tax (Net Income)	-30.33	-33.56	-21.76	-29.77	-29.03	-15.89
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-15.89

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	11.59	15.01	5.98	26.07	52.19	78.99
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.19	0.27	5.59	5.33	0.41	1.48
Current Liabilities	9.31	6.85	5.36	6.82	4.82	3.62
Total Liabilities	30.40	22.13	16.93	38.22	57.42	84.09

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	12.36	12.44	11.73	11.94	11.83	11.59
Current Assets	8.72	9.69	5.19	26.27	45.60	72.50
Total Assets	30.40	22.13	16.93	38.22	57.42	84.09
Total Debt*	0.29	0.36	0.48	0.57	0.45	0.16
Net Current Assets	-0.59	2.83	-0.17	19.46	40.78	68.88

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-22.74	-23.86	-24.10	-27.64	-18.95
Cash Flow from Investing Activities	--	--	-0.01	-0.12	-0.07	-0.02
Cash from Financing Activities	--	27.28	4.64	4.65	-0.02	74.72
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-16.62	-10.49	-160.97	-371.65	-380.41	-208.58
Cash EPS ($)	--	-10.46	-160.04	-370.10	-378.70	-206.43
Adjusted Book Value ($)	--	4.69	44.22	325.51	684.02	1,036.65
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-7.11	-176.49	-300.89	-362.24	-248.70
Free Cash Flow per Share ($)	--	-7.11	-176.59	-302.43	-363.12	-248.95

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-307.58	-131.48	-75.09	-44.05	-32.66
ROE (%)	-228.08	-319.85	-135.80	-76.07	-44.25	-32.81
ROA (%)	-101.25	-171.88	-78.93	-62.25	-41.02	-28.07
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-13.96	-54.21	26.89	-2.56	-82.62	19.49
Net Profit Growth (%)	-14.23	-54.21	26.89	-2.56	-82.62	8.42
EPS Growth (%)	85.51	0.93	0.57	0.02	-0.82	0.63
Book Value Growth (%)	117.68	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	0.05	-0.32	-0.01	0.00	0.00	-0.01
Price / Book Value	1.15	0.71	0.04	0.00	0.00	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.52	-0.06	0.17	0.77	1.47	4.49
Close Price ($)	2.79	3.31	42.50	321.90	397.50	697.50
High Price ($)	24.00	91.25	393.75	618.75	768.75	3,292.50
Low Price ($)	1.79	3.13	37.50	126.64	306.38	615.00
Market Cap ($ Cr)	13.83	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.02	0.08	0.02	0.01	0.00
Short term debt to equity ratio	0.01	0.01	0.02	0.00	0.00	0.00
Current Ratio	0.94	1.41	0.97	3.86	9.46	20.02
Quick Ratio	0.94	--	--	3.86	9.47	20.03
Interest Coverage	-387.81	--	--	--	-17.97	-2.25

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	0.00	-31.63	-55.12	1,274.86
Payable days	--	11,237.53	6,562.90	6,604.70	2,845.49	1,751.09
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.